TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer

Share :
Published: 2 May 2023
Views: 1903
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German

Dr Elena Sperk speaks to ecancer about TARGeted intraoperative radiotherapy with INTRABEAM as a boost for breast cancer treatment.

The TARGIT_BQR trial was a prospective phase IV study to evaluate real life data of IORT Boost.

The main goal of this trial was to see if IORT is as good as external radiotherapy at stopping breast cancer from coming back after surgery.

Dr Sperk discusses the results of the study and explores how these results could impact the future treatment of breast cancer. 

ecancer's filming has been kindly supported by Zeiss. ecancer is editorially independent and there is no influence over content.